WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

Market Cap	97.96B
Revenue (ttm)	102.51B
Net Income (ttm)	4.41B
Shares Out	13.20M
EPS (ttm)	334.25
PE Ratio	22.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,767
Average Volume	45,092
Open	7,410.00
Previous Close	7,430.00
Day's Range	7,370.00 - 7,550.00
52-Week Range	5,610.00 - 10,450.00
Beta	0.75
RSI	46.90
Earnings Date	Mar 14, 2025

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name...

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 330350

Financial Performance

In 2024, KOSDAQ:330350's revenue was 102.72 billion, an increase of 28.21% compared to the previous year's 80.12 billion. Earnings were 4.78 billion, a decrease of -39.88%.